Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P130008/S148

Model 4063 Dedicated Tray Sealer

Inspire Medical Systems · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP130008/S148

What did the FDA decide?

The FDA recorded decision OK30 on 2026-11-05 for PMA supplement P130008/S148, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 4063 Dedicated Tray Sealer and associated outer tray sealing nest equipment used to manufacture the Model 4063 Stimulation Lead. The device category is an implanted hypoglossal nerve stimulator for apnea, listed under the anesthesiology specialty with product code MNQ.

The recorded scope is installation of that sealing equipment for lead manufacture, not a new approval of the underlying system. The source lists no supporting documents, so the review basis and any conditions of the decision remain unknown. Whether the change affects sterility assurance, lead performance or labeling is not stated in the available record, and no clinical or legal conclusion follows from the decision code alone.

FDA approval order statement

approval for the installation of a new Tray Sealer and associated outer tray sealing nest equipment used for the manufacture of the Model 4063 Stimulation Lead
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Anesthesiology
Decision date
Nov 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P130008/S148
Regulatory pathway
PMA supplement
Product code
MNQ
Decision code
OK30
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.

Product code
MNQ
FDA device class
3

For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P130008 · Original PMA

    INSPIRE II UPPER AIRWAY STIMULATOR

  2. P130008/S148 received

    Application receipt date recorded by FDA.

  3. P130008/S144 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  4. P130008/S148 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130008

Product / regulatory recordCompanyPathwayDecision dateSource
Inspire Medical SystemsPMA approvalApr 30, 2014FDA
Model 3150 IPGP130008/S146
Inspire Medical SystemsPMA supplementOct 13, 2026FDA
Model 3150 IPGP130008/S147
Inspire Medical SystemsPMA supplementOct 22, 2026FDA
Inspire Medical SystemsPMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inspire Medical Systems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records